Devazepide is a potent, and orally bioavailable CCK1 (CCK-A) receptor antagonist that exhibits appetite-stimulant effects. It blocks the anorectic response to CCK-8 and increases food intake in rats following systemic and i.c.v administration. References: Wang HH, Portincasa P, Wang DQ. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice. Eur J Clin Invest. 2016 Feb;46(2):158-69. doi: 10.1111/eci.12580. Epub 2016 Jan 12. PubMed PMID: 26683129.

纯度：≥98%

CAS：103420-77-5